FDA Panel Considers Allowing Over-the-Counter Sales Of Low-Dose Cholesterol Medication
An FDA advisory committee on Thursday will meet to consider an application from Merck to market the 20-milligram dose of the anticholesterol medication Mevacor over the counter, the Newark Star-Ledger reports (Todd/Cohen, Newark Star-Ledger, 12/12). [click link for full article]
More: continued here
Filed under: Cholesterol on December 15th, 2007